Related Experiment Video
Updated: Feb 25, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Small-molecule CB002 restores p53 pathway signaling and represses colorectal cancer cell growth
Colby Richardson1, Shengliang Zhang1,2, Liz J Hernandez Borrero1
1a Penn State Hershey Cancer Institute , Hershey , PA , USA.
Abstract:
Much effort is currently focused on the p53 pathway. p53 is a key tumor suppressor, which is mutated or lost in many human cancers. Restoration of the p53 pathway holds the potential to induce selective cell death in tumor cells without harming normal cells that have intact p53 pathways. Most tumor cells express mutated p53 or suppress p53 by overexpression of MDM2. In this study, a compound referred to as CB002 with one closely related compound from the Chembridge library were evaluated for tumor cytotoxicity without affecting normal cells by restoration of the p53 pathway. A decrease of mutant p53 protein expression, restoration of inactivated p53, or some activation of p73 are candidate mechanisms this agent could cause tumor cell apoptosis and growth arrest. We further show that CB002 activates p53 pathway signaling in part via p73 in p53 mutant cancer cell lines. However, it is important to note that we have not established a role for p73 in the anti-tumor effect of CB002 or R1. CB002 causes tumor cell death with synergistic effects with traditional chemotherapeutics CPT-11 and 5-FU.
Insights
Researchers explored CB002 to restore the p53 tumor suppressor pathway, aiming to induce cancer cell death. This compound shows potential for targeted cancer therapy, even synergizing with chemotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- The p53 pathway is crucial for tumor suppression, frequently mutated or lost in human cancers.
- Restoring p53 function offers a strategy for selective cancer cell death, sparing normal cells.
- Tumor cells often evade p53 by mutation or MDM2 overexpression.
Purpose of the Study:
- To evaluate the tumor cytotoxicity of compound CB002 and a related analog.
- To investigate the potential of CB002 to restore the p53 pathway in cancer cells.
- To determine if CB002 induces tumor cell apoptosis and growth arrest selectively.
Main Methods:
- Screening of compounds from the Chembridge library, focusing on CB002 and a related analog.
- Assessment of tumor cell cytotoxicity and effects on normal cells.
- Analysis of p53 pathway signaling, including p53 and p73 activation, in cancer cell lines.
Main Results:
- CB002 demonstrated tumor cytotoxicity without harming normal cells, suggesting p53 pathway restoration.
- CB002 was shown to activate p53 pathway signaling, partly through p73, in p53-mutant cancer cells.
- CB002 exhibited synergistic effects with chemotherapeutics CPT-11 and 5-FU, enhancing tumor cell death.
Conclusions:
- Compound CB002 shows promise as a therapeutic agent for restoring p53 function in cancer.
- CB002 induces tumor cell death and growth arrest, potentially via p53 and p73 pathway activation.
- CB002 enhances the efficacy of conventional chemotherapy, offering a potential combination therapy strategy.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Drugs that Stabilize Microtubules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity